(NASDAQ: ATRC) Atricure's forecast annual revenue growth rate of 13.35% is forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 10.55%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.11%.
Atricure's revenue in 2026 is $534,528,000.On average, 11 Wall Street analysts forecast ATRC's revenue for 2026 to be $30,663,971,254, with the lowest ATRC revenue forecast at $29,342,016,481, and the highest ATRC revenue forecast at $31,667,142,660. On average, 11 Wall Street analysts forecast ATRC's revenue for 2027 to be $34,473,432,482, with the lowest ATRC revenue forecast at $32,597,591,610, and the highest ATRC revenue forecast at $35,842,706,661.
In 2028, ATRC is forecast to generate $38,954,829,275 in revenue, with the lowest revenue forecast at $37,117,840,126 and the highest revenue forecast at $40,370,924,761.